HEALTHCARE CAPITAL CORP-CL A (HCCC)
Common Stock
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp....
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has...
Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse Events
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that all ten...
Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has...
Moore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law Firm
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation
Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and Warrants
H/Cell Energy changes name to Vision Hydrogen (OTCMKTS:HCCC)
H/Cell Energy (OTCQB:HCCC) announces restructuring changes in order to take advantage of the hydrogen production market opportunities.Company has changed its name to Vision Hydrogen Corporation and will focus on the production of hydrogen for clean energy applications including transportation and power requirements.Additionally, company has effectuated a 1-for-20 reverse stock split of its issued and outstanding common stock, effective as of the opening of market trading on October 6, 2020, the Company will trade under the symbol HCCCD for 20 business days to designate the Reverse Split, after which, the ticker symbol will change to VIHD.Company also relocated its corporate headquarters from Dallas, TX to Jersey City, NJ.
H/Cell Energy Announces Restructuring Changes
H/Cell Energy Reports FY2020 First Quarter Financial Results
H/Cell Energy Obtains Contract to Equip Coronavirus Tents
H/Cell Energy Reports FY2019 Year End Financial Results
$800k in New Contracts Awarded to H/Cell Energy
H/Cell Energy Awarded $600k in New Projects
H/Cell Energy Reports FY2019 Third Quarter Financial Results
H/Cell Energy Receives $700k in New Contracts
H/Cell Energy Adds $500k in New Projects to Backlog
$1.4 Million in New Contracts Awarded to H/Cell Energy
H/Cell Energy Completes Over $1.2 Million in Projects
H/Cell Energy Reports FY2019 Second Quarter Financial Results
H/Cell Energy Announces $3 Million Equity Investment Commitment
H/Cell Energy Reports FY2019 First Quarter Financial Results
H/Cell Energy Reports FY2018 Year End Financial Results
H/Cell Energy Commended By Australian Energy Minister
H/Cell Energy Awarded Contracts and Panel Selection
H/Cell Energy Reports FY2018 Third Quarter Financial Results
H/Cell Energy Reports FY2018 Second Quarter Financial Results
H/Cell Energy Reports FY2018 First Quarter Financial Results